Maury Raycroft
Analyst
Jeffries
Equibles does not estimate personal net worth.
About Maury Raycroft
Maury Raycroft is recorded as Analyst at Jeffries. Maury Raycroft has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Sangamo Therapeutics, Inc on March 30, 2026. Those appearances were for Sangamo Therapeutics, Inc (SGMOQ), Beam Therapeutics Inc. (BEAM) and KalVista Pharmaceuticals, Inc.. The companies whose calls Maury Raycroft spoke on are classified in the Healthcare sector.
Maury Raycroft on recent calls
“Just to start off, can you provide more color on the revised timing for the FABRI BLA submission? What PPQ and other CMC-related activities are the primary gating factors here?”
“For the in vitro data that you have for the different variants, can you just provide more specifics on how much of that you already have?”
“Just based on the patient interest you're seeing from your awareness website and doctor interest, how are you setting expectations for the early launch?”
Affiliation history
-
Jeffries
Analyst
Transcript header (unverified)
Current
Company network
KalVista Pharmaceuticals, Inc.
Biotechnology · Healthcare
1 appearance
Latest appearance 2025-07-07
Recent activity
-
-
-
Conference
Ekterly FDA Approval Conference Call
KalVista Pharmaceuticals, Inc.